These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3933053)

  • 21. Protooncogene expression during the cell cycle.
    Kaczmarek L
    Lab Invest; 1986 Apr; 54(4):365-76. PubMed ID: 3007866
    [No Abstract]   [Full Text] [Related]  

  • 22. Induction of receptors for interleukin 2 requires T cell Ag:Ia receptor crosslinking and interleukin 1.
    Kaye J; Janeway CA
    Lymphokine Res; 1984; 3(4):175-82. PubMed ID: 6436584
    [No Abstract]   [Full Text] [Related]  

  • 23. Early immune response and regulation of IL-2 receptor subunits.
    Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A
    Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depressed interleukin 2 receptor expression in acquired immune deficiency and lymphadenopathy syndromes.
    Prince HE; Kermani-Arab V; Fahey JL
    J Immunol; 1984 Sep; 133(3):1313-7. PubMed ID: 6235286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inducible knockout of the interleukin-2 receptor alpha chain: expression of the high-affinity IL-2 receptor is not required for the in vitro growth of HTLV-I-transformed cell lines.
    Richardson JH; Waldmann TA; Sodroski JG; Marasco WA
    Virology; 1997 Oct; 237(2):209-16. PubMed ID: 9356333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional consequences of costimulation by ICAM-1 on IL-2 gene expression and T cell activation.
    Zuckerman LA; Pullen L; Miller J
    J Immunol; 1998 Apr; 160(7):3259-68. PubMed ID: 9531282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell activation.
    MacDonald HR; Nabholz M
    Annu Rev Cell Biol; 1986; 2():231-53. PubMed ID: 3548767
    [No Abstract]   [Full Text] [Related]  

  • 29. Regulation of interleukin 2 receptor expression on murine cytotoxic T lymphocyte clones.
    Andrew ME; Braciale VL; Braciale TJ
    J Immunol; 1984 Feb; 132(2):839-44. PubMed ID: 6418812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
    Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of IL-2 gene regulation in c-fos transgenic mice. Evidence for an enhancement of IL-2 expression in splenic T cells stimulated via TCR/CD3 complex.
    Ochi Y; Koizumi T; Kobayashi S; Phuchareon J; Hatano M; Takada M; Tomita Y; Tokuhisa T
    J Immunol; 1994 Oct; 153(8):3485-90. PubMed ID: 7930571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pattern of cytokine gene expression induced in rat T cells specific for myelin basic protein depends on the type and quality of antigenic stimulus.
    Sun D; Hu XZ; Shah R; Coleclough C
    Cell Immunol; 1995 Nov; 166(1):1-8. PubMed ID: 7585969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-2 and its receptor: structure and functional expression of the genes.
    Taniguchi T; Fujita T; Hatakeyama M; Mori H; Matsui H; Sato T; Hamuro J; Minamoto S; Yamada G; Shibuya H
    Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 1():577-86. PubMed ID: 3107881
    [No Abstract]   [Full Text] [Related]  

  • 34. Reishi immuno-modulation protein induces interleukin-2 expression via protein kinase-dependent signaling pathways within human T cells.
    Hsu HY; Hua KF; Wu WC; Hsu J; Weng ST; Lin TL; Liu CY; Hseu RS; Huang CT
    J Cell Physiol; 2008 Apr; 215(1):15-26. PubMed ID: 18189229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular biology of chromosomal aberrations in leukemia/lymphoma.
    Kagan J
    Hematol Pathol; 1993; 7(3):159-201. PubMed ID: 8244909
    [No Abstract]   [Full Text] [Related]  

  • 36. IL-2-dependent expression of genes involved in cytoskeleton organization, oncogene regulation, and transcriptional control.
    Herblot S; Chastagner P; Samady L; Moreau JL; Demaison C; Froussard P; Liu X; Bonnet J; Thèze J
    J Immunol; 1999 Mar; 162(6):3280-8. PubMed ID: 10092780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effect of cyclosporin A on the expression of T and B lymphocyte activation antigens.
    Lillehoj HS; Malek TR; Shevach EM
    J Immunol; 1984 Jul; 133(1):244-50. PubMed ID: 6327823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen-dependent regulation of interleukin 2 receptor expression on cloned human cytotoxic T lymphocytes.
    Kaplan DR; Braciale VL; Braciale TJ
    J Immunol; 1984 Oct; 133(4):1966-9. PubMed ID: 6206143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urokinase receptor. An activation antigen in human T lymphocytes.
    Nykjaer A; Møller B; Todd RF; Christensen T; Andreasen PA; Gliemann J; Petersen CM
    J Immunol; 1994 Jan; 152(2):505-16. PubMed ID: 8283034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the interleukin-2 gene.
    Riegel JS; Corthesy B; Flanagan WM; Crabtree GR
    Chem Immunol; 1992; 51():266-98. PubMed ID: 1567544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.